New pill shows promise for Long-Term arthritis control
NCT ID NCT04049448
First seen Nov 17, 2025 · Last updated May 08, 2026 · Updated 24 times
Summary
This study looked at the long-term safety of a drug called ABX464 in 40 adults with moderate to severe rheumatoid arthritis. All participants had already completed a 12-week treatment course. The goal was to see if taking the drug for up to 52 more weeks was safe and helped keep the disease under control. This is not a cure, but a way to manage symptoms and slow disease activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHR d'Orléans
Orléans, France
-
CHU DE MONTPELLIER - Hôpital Lapeyronie
Montpellier, France
-
CHU de Brest - Hôpital Cavale Blanche
Brest, France
-
CMed Rehabilitációs és Diagnosztikai Központ
Székesfehérvár, Hungary
-
CRU Hungary Ltd.
Miskolc, Hungary
-
ClinicMed Daniluk, Nowak Sp. J.
Bialystok, Poland
-
Cliniques Universitaires Saint-Luc
Brussels, Belgium
-
Complex Medical Centre - Déli Klinika
Budapest, Hungary
-
Medyczne Centrum Hetmańska
Poznan, Poland
-
NZOZ Lecznica MAK-MED S.C.
Nadarzyn, Poland
-
National Institute of Geriatrics
Warsaw, Poland
-
Pratia MCM
Krakow, Poland
-
UZ Gent
Ghent, Belgium
-
Zespół Poradni Specjalistycznych REUMED
Lublin, Poland
Conditions
Explore the condition pages connected to this study.